Flavonoids exert distinct modulatory actions on cyclooxygenase 2 and NF-B in an intestinal epithelial cell line (IEC18)

British Journal of Pharmacology

Volumn 160, Issue 7, 2010, Pages 1714-1726

  Lopez Posadas R ^a   Ballester, I ^b   Mascaraque, C ^a   Suarez M D ^a   Zarzuelo, A ^a   Martinez Augustin O ^a   Sanchez De Medina F ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

cyclooxygenase 2; flavonoids; intestinal epithelial cells; NF B

Indexed keywords

APIGENIN; CHRYSIN; CYCLOOXYGENASE 2; DAIDZEIN; DIOSMETIN; FLAVONOID; GENISTEIN; HESPERETIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KAEMPFEROL; LIPOPOLYSACCHARIDE; LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P50; QUERCETIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I;

ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; INFLAMMATION; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL NUCLEUS; CELL SURVIVAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; FLAVONOIDS; INTESTINAL MUCOSA; L-LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDES; LUCIFERASES; MOLECULAR STRUCTURE; NF-KAPPA B; PLASMIDS; PROTEIN TRANSPORT; RATS;

EID: 77954323528     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00827.x     Document Type: Article

References (39)

1. Ajuebor MN, Singh A, Wallace JL (2000). Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. Am J Physiol Gastrointest Liver Physiol 279:G238 G244.
2. Alexander SPH, Mathie A, Peters JA (2009). Guide to Receptors and Channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1 S1 S254.
3. Ballester I, Camuesco D, Gálvez J, Sánchez de Medina F, Zarzuelo A (2006). Flavonoids and inflammatory bowel disease. Ars Pharmaceutica 47:5 21.
4. Blonska M, Bronikowska J, Pietsz G, Czuba ZP, Scheller S, Krol W (2004). Effects of ethanol extract of propolis (EEP) and its flavones on inducible gene expression in J774A.1 macrophages. J Ethnopharmacol 91:25 30.
5. Bonnekoh B, Wevers A, Jugert F, Merk H, Mahrle G (1989). Colorimetric growth assay for epidermal cell cultures by their crystal violet binding capacity. Arch Dermatol Res 281:487 490.
6. Brown SL, Riehl TE, Walker MR, Geske MJ, Doherty JM, Stenson WF et al. (2007). Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J Clin Invest 117:258 269.
7. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, Podolsky DK (2000). Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 164:966 972.
8. Cheon JH, Kim JS, Kim JM, Kim N, Jung HC, Song IS (2006). Plant sterol guggulsterone inhibits nuclear factor-kappaB signaling in intestinal epithelial cells by blocking IkappaB kinase and ameliorates acute murine colitis. Inflamm Bowel Dis 12:1152 1161.
9. Comalada M, Ballester I, Bailon E, Sierra S, Xaus J, Galvez J et al. (2006). Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. Biochem Pharmacol 72:1010 1021.
10. Eckmann L, Stenson WF, Savidge TC, Lowe DC, Barrett KE, Fierer J et al. (1997). Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin h synthase-2 expression and prostaglandin E2 and F2alpha production. J Clin Invest 100:296 309.
11. Fornai M, Blandizzi C, Colucci R, Antonioli L, Bernardini N, Segnani C et al. (2005). Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice. Gut 54:608 616.
12. Galvez J, Cruz T, Crespo E, Ocete MA, Lorente MD, Sanchez de Medina F et al. (1997). Rutoside as mucosal protective in acetic acid-induced rat colitis. Planta Med 63:409 414.
13. Gasparian AV, Guryanova OA, Chebotaev DV, Shishkin AA, Yemelyanov AY, Budunova IV (2009). Targeting transcription factor NFB: comparative analysis of proteasome and IKK inhibitors. Cell Cycle 8:1559 1566.
14. Grishin AV, Wang J, Potoka DA, Hackam DJ, Upperman JS, Boyle P et al. (2006). Lipopolysaccharide induces cyclooxygenase-2 in intestinal epithelium via a noncanonical p38 MAPK pathway. J Immunol 176:580 588.
15. Inan MS, Tolmacheva V, Wang QS, Rosenberg DW, Giardina C (2000). Transcription factor NF-kappaB participates in regulation of epithelial cell turnover in the colon. Am J Physiol Gastrointest Liver Physiol 279:G1282 G1291.
16. Jobin C, Sartor RB (2000). The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection. Am J Physiol Cell Physiol 278:C451 C462.
17. Jobin C, Morteau O, Han DS, Balfour Sartor R (1998). Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells. Immunology 95:537 543.
18. Kaneko M, Takimoto H, Sugiyama T, Seki Y, Kawaguchi K, Kumazawa Y (2008). Suppressive effects of the flavonoids quercetin and luteolin on the accumulation of lipid rafts after signal transduction via receptors. Immunopharmacol Immunotoxicol 30:867 882.
19. Kawai T, Akira S (2007). Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 13:460 469.
20. Kim JS, Narula AS, Jobin C (2005). Salvia miltiorrhiza water-soluble extract, but not its constituent salvianolic acid B, abrogates LPS-induced NF-kappaB signalling in intestinal epithelial cells. Clin Exp Immunol 141:288 297.
21. Kwon KH, Murakami A, Tanaka T, Ohigashi H (2005). Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochem Pharmacol 69:395 406.
22. Longo WE, Panesar N, Mazuski J, Kaminski DL (1998). Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents. Prostaglandins Other Lipid Mediat 56:325 339.
23. López-Posadas R, Ballester I, Abadía A, Suárez MD, Zarzuelo A, Martínez-Augustin O et al. (2008). Effect of flavonoids on rat splenocytes, a structure-activity relationship study. Biochem Pharmacol 76:495 506.
24. MacNaughton WK, Cushing K (2000). Role of constitutive cyclooxygenase-2 in prostaglandin-dependent secretion in mouse colon in vitro. J Pharmacol Exp Ther 293:539 544.
25. Mochizuki M, Hasegawa N (2004). Therapeutic efficacy of pycnogenol in experimental inflammatory bowel diseases. Phytother Res 18:1027 1028.
26. Newberry RD, Stenson WF, Lorenz RG (1999). Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat Med 5:900 906.
27. Ohtsuka Y, Lee J, Stamm DS, Sanderson IR (2001). MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine. Gut 49:526 533.
28. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T et al. (1997). Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272:21096 21103.
29. Reinecker HC, Podolsky DK (1995). Human intestinal epithelial cells express functional cytokine receptors sharing the common gamma c chain of the interleukin 2 receptor. Proc Natl Acad Sci U S A 92:8353 8357.
30. Ruiz PA, Braune A, Holzlwimmer G, Quintanilla-Fend L, Haller D (2007). Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. J Nutr 137:1208 1215.
31. Sanchez de Medina F, Galvez J, Romero JA, Zarzuelo A (1996). Effect of quercitrin on acute and chronic experimental colitis in the rat. J Pharmacol Exp Ther 278:771 779.
32. Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, Stenson WF (1998). Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115:297 306.
33. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD et al. (1985). Measurement of protein using bicinchoninic acid. Anal Biochem 150:76 85.
34. Stenson WF (2007). Prostaglandins and epithelial response to injury. Curr Opin Gastroenterol 23:107 110.
35. Wallace JL (2006). COX-2: a pivotal enzyme in mucosal protection and resolution of inflammation. ScientificWorldJournal 6:577 588.
36. Weylandt KH, Kang JX, Wiedenmann B, Baumgart DC (2007). Lipoxins and resolvins in inflammatory bowel disease. Inflamm Bowel Dis 13:797 799.
37. Xagorari A, Papapetropoulos A, Mauromatis A, Economou M, Fotsis T, Roussos C (2001). Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J Pharmacol Exp Ther 296:181 187.
38. Yan SR, Joseph RR, Wang J, Stadnyk AW (2006). Differential pattern of inflammatory molecule regulation in intestinal epithelial cells stimulated with IL-1. J Immunol 177:5604 5611.
39. Zamuner SR, Warrier N, Buret AG, MacNaughton WK, Wallace JL (2003). Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction. Gut 52:1714 1720.